- Home
- FLS vs CORT Comparison
FLS vs CORT Comparison
Compare FLS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLS
- CORT
- Stock Information
- Founded
- FLS 1790
- CORT 1998
- Country
- FLS United States
- CORT United States
- Employees
- FLS N/A
- CORT N/A
- Industry
- FLS Fluid Controls
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- FLS Industrials
- CORT Health Care
- Exchange
- FLS Nasdaq
- CORT Nasdaq
- Market Cap
- FLS 7.1B
- CORT 7.6B
- IPO Year
- FLS N/A
- CORT N/A
- Fundamental
- Price
- FLS $56.49
- CORT $69.53
- Analyst Decision
- FLS Strong Buy
- CORT Strong Buy
- Analyst Count
- FLS 9
- CORT 4
- Target Price
- FLS $66.89
- CORT $139.00
- AVG Volume (30 Days)
- FLS 1.5M
- CORT 644.6K
- Earning Date
- FLS 10-27-2025
- CORT 10-29-2025
- Dividend Yield
- FLS 1.49%
- CORT N/A
- EPS Growth
- FLS 13.91
- CORT N/A
- EPS
- FLS 2.21
- CORT 1.11
- Revenue
- FLS $4,646,070,000.00
- CORT $716,080,000.00
- Revenue This Year
- FLS $6.59
- CORT $30.62
- Revenue Next Year
- FLS $4.10
- CORT $37.68
- P/E Ratio
- FLS $25.60
- CORT $62.97
- Revenue Growth
- FLS 3.15
- CORT 25.71
- 52 Week Low
- FLS $37.34
- CORT $37.82
- 52 Week High
- FLS $65.08
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- FLS 62.82
- CORT 45.26
- Support Level
- FLS $54.79
- CORT $67.32
- Resistance Level
- FLS $57.57
- CORT $74.79
- Average True Range (ATR)
- FLS 1.09
- CORT 2.36
- MACD
- FLS 0.25
- CORT 0.14
- Stochastic Oscillator
- FLS 78.82
- CORT 29.58
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.